|
Video: What is a Stock Split?
|
|
Kiromic BioPharma is an artificial intelligence driven, end-to-end Chimeric Antigen Receptor T cell and gene therapy company. Co.'s Procel, Isocel, and Deltacel platforms consist of allogeneic cell therapy product candidates that are in the preclinical development stage. Co.'s Procel product candidate consists of engineered GDTs that target PD-L1. Co.'s Isocel product candidate consists of engineered Gamma Delta T cells that target Mesothelin Isoform 2 positive tumors. Co.'s Deltacel product candidate consists of non-engineered GDTs that have been expanded and activated ex- vivo through a process, and are used to treat solid tumors regardless of the specific tumor antigen expression. According to our KRBP split history records, KRBP has had 1 split. | |
|
KRBP (KRBP) has 1 split in our KRBP split history database. The split for KRBP took place on March 13, 2023. This was a 1 for 30 reverse split, meaning for each 30 shares of KRBP owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 33.3333333333333 share position following the split.
When a company such as KRBP conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the KRBP split history from start to finish, an original position size of 1000 shares would have turned into 33.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into KRBP shares, starting with a $10,000 purchase of KRBP, presented on a split-history-adjusted basis factoring in the complete KRBP split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/19/2020 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$338.70 |
|
End price/share: |
$2.50 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.26% |
|
Average Annual Total Return: |
-75.42% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$73.77 |
|
Years: |
3.50 |
|
|
|
Date |
Ratio |
03/13/2023 | 1 for 30 |
|
|